HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yokukansan (TJ-54) for treatment of very-late-onset schizophrenia-like psychosis: an open-label study.

AbstractBACKGROUND:
Although schizophrenia affects all age groups, late or very-late-onset schizophrenia-like psychosis has not been well studied, and various treatment issues remain unresolved. The objective of the present study was to evaluate the efficacy and safety of yokukansan (TJ-54), Japanese herbal medicine, monotherapy in a diagnostically homogenous group of elderly patients without cognitive impairment suffering from very-late-onset schizophrenia.
METHODS:
Forty patients of mean age 73.1±4.8 years, fulfilling both the recent consensus criteria for very late-onset schizophrenia-like psychosis and the DSM-IV-TR criteria for schizophrenia, were assessed by the brief psychiatric rating scale, the clinical global impression scale-severity, and positive and negative syndrome scale at baseline and after 4 weeks administration of TJ-54 (2.5-7.5 g/day). In addition, abnormal movements were evaluated with the Simpson-Angus scale, Barnes Akathisia scale, and abnormal involuntary movement scale.
RESULTS:
A highly significant (p<0.001) improvement on all measures of psychotic symptomatology was observed in all patients. TJ-54 was very well tolerated by the patients, and no clinically significant adverse effects were observed. Scores on all abnormal movement scales did not differ significantly prior to and after TJ-54 treatment.
CONCLUSION:
Preliminary results indicate that TJ-54 appears to be an efficacious and safe herbal medicine for treatment of very-late-onset schizophrenia-like psychosis.
AuthorsTsuyoshi Miyaoka, Rei Wake, Motohide Furuya, Kristian Liaury, Masa Ieda, Kazunori Kawakami, Keiko Tsuchie, Michiyo Fukushima, Kotomi Ishihara, Tomoko Araki, Sadayuki Hashioka, Jun Horiguchi
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 20 Issue 7 Pg. 654-8 (May 15 2013) ISSN: 1618-095X [Electronic] Germany
PMID23453830 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier GmbH. All rights reserved.
Chemical References
  • Antipsychotic Agents
  • Drugs, Chinese Herbal
  • Plant Preparations
  • Yi-Gan San
Topics
  • Age of Onset
  • Aged
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Drugs, Chinese Herbal (therapeutic use)
  • Female
  • Humans
  • Japan
  • Male
  • Plant Preparations (adverse effects, therapeutic use)
  • Psychotic Disorders (drug therapy, psychology)
  • Schizophrenia (drug therapy, epidemiology, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: